Expanding Board of Directors to Add to Commercial Expertise Read More »

The American Pharmacists Association and 12 other pharmacy organizations told a special committee of the National Academies of Science, Engineering and Medicine (NASEM) that pharmacists should be given tier 1 priority status in the allocation and distribution of COVID-19 vaccine(s). Read More »

Mylan N.V. (NASDAQ: MYL) announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the hospital/clinic level of four lots of Amiodarone HCl Injection, USP 450 mg/9 mL, packaged in cartons of 10 single-dose 9 mL vials and Tranexamic Acid Injection, USP 1000 mg/10 mL, packaged in cartons of 10 single-dose 10 mL vials. Read More »

Company orders additional product amid reported industry shortage Read More »

For patients with non-low back, musculoskeletal injuries, non-steroidal anti-inflammatory drugs should be a first-line treatment for acute pain that lasts no more than four weeks, according to a new guideline from the American College of Physicians and the American Academy of Family Physicians. Read More »

The high costs of medical care are well-documented, but those battling significant illnesses have found a measure of economic relief through manufacturer cost-sharing assistance programs. Read More »

The push for a COVID-19 vaccine is “remarkably positioned to succeed,” Jenny Bryant, executive vice president of policy and research for the Pharmaceutical Research and Manufacturers of America (PhRMA), said. Read More »

In a recent response to President Donald Trump's executive order regarding essential medicines, the Association for Accessible Medicines highlighted the importance of generic and biosimilar medicines for ensuring the health and well-being of U.S. residents. Read More »

Karmanos Specialty Pharmacy (KSP) is pleased to announce that it has received full accreditation from the Utilization Review Accreditation Commission (URAC). This accreditation is valid for three years. Read More »

Company increases U.S. manufacturing capacity of drug to ensure uninterrupted supply amid industry shortage Read More »

The best practices for genetic testing for the management of cardiovascular diseases that are inherited have been outlined by the American Heart Association (AHA). Read More »

A recent letter to Congressional leaders from a coalition headed by the National Forum for Heart Disease and Stroke Prevention urges Congress to include payments for front-line pharmacists in the next COVID-19 relief package by designating them as providers under Medicare Part B. Read More »

Medly Continues Nationwide Expansion With the Launch of Digital Pharmacy Services, Including Free, Same-Day Delivery, Into the Baltimore Market Read More »

The reliability, quality and safety of our nation's drug supply chain are essential to the nation's security and health and well-being of the American public. Read More »

PQS adds former Senior Advisor to the Secretary for Drug Pricing Reform, U.S. Department of Health and Human Services to its Board of Directors Read More »

Humana Pharmacy, a division of Humana Inc. (NYSE: HUM), has been named the best in Mail Order Pharmacy customer satisfaction in the J.D. Power 2020 U.S. Pharmacy Study. It’s the third consecutive year that Humana has received the prestigious honor. Read More »

A recent pilot study conducted by Johns Hopkins Medicine may show promise for lowering cholesterol in some patients by using a drug that inhibits a protein involved in cholesterol metabolism. Read More »

James Capretta, a resident fellow and health analyst with the American Enterprise Institute (AEI), a Washington D.C.-based think tank that researches government, economics and social welfare, called for a coordinated effort to distribute vaccine worldwide to prevent COVID-19 infection. Read More »

A recent report by the biopharmaceutical industry shows that there are over 400 medicines and vaccines in development to treat infectious diseases, including COVID-19, according to a news release by PhRMA. Read More »

The majority receiving COVID-19 experimental treatments are those patients hospitalized with the coronavirus, Cedars-Sinai Hospital Epidemiology Director Jonathan Grein said in a recent news release. Read More »